Cancer
Cancer Biopsy Analyses for Customized Therapy
Cell Therapy in the Management of Cancer and other Diseases
Enhancing the Detection of Cervical Cancer--Reducing
Undetected Abnormalities on
Pap Smears
Multidrug Resistance in Cancer Chemotherapy
Supportive Therapies for Cancer Chemotherapy
Targeted DNA-Probe Technology for Treatment ofChronic
Viral Diseases and Cancer
Ultrasound in Breast Cancer Diagnosis
Enhancing the Detection of Cervical Cancer--Reducing Undetected Abnormalities on Pap Smears
Although the Pap smear test has been one of the most successful screening technologies ever introduced in the management of cancer, the incidence of undetected abnormalities on test slides continues to be unduly large. The underlying factors are various, and include problems of sampling, detection and identification. Government regulation of cytopathology laboratory practices have been only partially successful. New technologies to reduce these problems are now becoming available, but are meeting considerable resistance, largely for economic reasons. Communicore is engaged in a broad-based program to tackle this important women's health issue.
Some related materials produced by Communicore:
Web Site
http://www.paptest.com
Newsletter
Early Detection
White Paper
(Under development)
Issues Video
(In production)
Consensus Document
(Under development)
Supportive Therapies for Cancer Chemotherapy
The inherent toxicity of cancer chemotherapy underscores the importance of quality of life as a treatment goal along with prolonging survival. As the potential benefit of chemotherapy increases, so does the responsibility to attend to the risks and side effects--physical, psychological, economic and societal--of that treatment.
Some related materials produced by Communicore:
White Paper
Supportive
Therapies for Cancer Chemotherapy Patients
Newsletter
Pro Vita
Issues Video
Supportive
Therapies for Cancer Chemotherapy Patients:The Intersection of Quality of Life and Economics
Ultrasound in Breast Cancer Diagnosis
Advances in breast cancer diagnosis lag behind efforts to encourage widespread screening. Biopsy is effective, but costly, invasive, and can cause physical and emotional trauma. One solution--high resolution digital ultrasound--can be used as an adjunct to mammography to better distinguish between benign and malignant breast masses.
Some related materials produced by Communicore:
White Paper
Breast
Cancer Diagnosis
Newsletter
Frontiers in Ultrasound
Study Report
High Definition Imaging: Ultrasound
in the Diagnosis of Breast Cancer: Summary of
an International Multicenter Study
| Information Center Main Page | | What's Hot | Home
| |